🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07640659
Starting soon Not applicable

Using Breath Tests to Study Gut Sulfur Changes During Dietary Therapy

NCT07640659 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-06-01
Last updated
2026-06-11

Condition(s) studied

Ulcerative Colitis (UC)

Investigational drug(s) / intervention(s)

Elemental formula (mBiota Elemental, Good LFE, Santa Monica, CA)Reduced Sulfur dietHabitual Diet

Elemental formula (mBiota Elemental, Good LFE, Santa Monica, CA): Elemental liquid diets (EDs) are a subset of Exclusive Enteral Nutrition (EEN). Similar to EEN, they are nutritionally complete formulas, but differ in that they consist of free amino acids, monosaccharides, and fatty acids instead of whole, intact macronutrients, which are designed for optimal digestibility and to minimize antigenicity. EDs have been shown to reduce immune activation, favourably modulate the microbiota, suppress proinflammatory cytokines, support epithelial repair, and exclude common dietary additives that may provoke inflammation.

Reduced Sulfur diet: This diet excludes high sulfur foods (e.g., red meat, seafood, eggs), cruciferous vegetables, dried fruits, and fermented beverages. It also accounts for sulfate intake from drinking water and processed food additives.

Habitual Diet: Participants randomized to the comparator group will continue their usual dietary intake for 10 weeks without specific dietary restrictions.

Study summary

This study aims to test whether a short liquid-based diet, followed by a low-sulfur eating plan, is safe, manageable, and helpful for people with mild to moderate ulcerative colitis. Investigators want to see if this approach can improve gut health, lower inflammation, and reduce symptoms. Investigators will also test breath samples as an easy, non-invasive way to track gut bacteria activity and disease changes. Investigators believe this diet plan can reduce harmful gut bacteria that produce irritating sulfur compounds, leading to better gut health and measurable improvements that can be detected through breath testing.

Eligibility

Sex
ALL
Min age
19 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Age 19-70 years. =Diagnosis of mild-to-moderate ulcerative colitis, defined by a partial Mayo score (pMayo) of 2-7. * Evidence of active inflammation at enrollment, defined as: * C-reactive protein (CRP) \> 5 mg/L; or * Fecal calprotectin (FCP) \> 200 µg/g. * Receiving stable medical therapy for ulcerative colitis for at least 8 weeks prior to enrollment. * No corticosteroid use at the time of recruitment. * Under consideration by the treating physician for treatment escalation or biologic switch due to inadequate response to current therapy. Exclusion Criteria: * Partial Mayo score (pMayo) \> 7. * Pregnant or breastfeeding. * Body mass index (BMI) \< 18 kg/m². * History of an eating disorder. * Severe psychiatric disorder. * Severe medical conditions, including: * Active cancer; * Significant cardiovascular disease; * Diabetes mellitus; or * Severe food allergies. * Known allergy or intolerance to corn, dextrose, or maltodextrin. * Antibiotic use within 3 months prior to enrollment. * Probiotic use within 3 months prior to enrollment. * Use of herbal anti-inflammatory supplements during the study period, including but not limited to: * Serrapeptidase; * Curcumin; * Boswellia; or * Bromelain. * History of major gastrointestinal surgery, including: * Ostomy; * Total colectomy; or * Short bowel syndrome. * Inability or unwillingness to comply with study procedures, including anticipated travel or other commitments that may interfere with participation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of British Columbia-Okanagan Kelowna British Columbia

More University of British Columbia trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07640659 on ClinicalTrials.gov ↗ ← All trials in Canada